Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches.

International journal of molecular sciences - 30 Jan 2022

Sadiea Rahila Zannat, Sultana Shahnaj, Chaki Bijan Mohon, Islam Tasnim, Dash Sharmy, Akter Sharmin, Islam Md Sayeedul, Kazi Taheruzzaman, Nagata Abir, Spagnuolo Rocco, Mancina Rosellina Margherita, Hossain Md Golzar

Abstract excerpt

Hepatitis B virus infection (HBV) is one of the most common causes of hepatitis, and may lead to cirrhosis or hepatocellular carcinoma. According to the World Health Organization (WHO), approximately 296 million people worldwide are carriers of the hepatitis B virus. Various nucleos(t)ide analogs, which specifically suppress viral replication, are the main treatment agents for HBV infection. However, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Development

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Hepatitis B

Share to Hepatitis B virus

Share to Molecular Structure

Share to Phytochemicals

Share to Virus Replication

Source

Open in PubMed Open full text

Identifiers

PMID: 35163539
DOI: 10.3390/ijms23031617
PMCID: PMC8836293

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches.PMID 35163539Read ↗

Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA.Semantic proximity Read ↗

Chronic hepatitis B therapy: available drugs and treatment guidelines.Semantic proximity Read ↗

The progress of molecules and strategies for the treatment of HBV infectionSemantic proximity Read ↗

Novel therapies and potential therapeutic targets in the management of chronic hepatitis B.Semantic proximity Read ↗

Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNASemantic proximity Read ↗

Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human PathogenSemantic proximity Read ↗

Update on hepatitis B virus infection.Semantic proximity Read ↗

Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?Semantic proximity Read ↗

HBV cccDNA─A Culprit and Stumbling Block for the Hepatitis B Virus Infection: Its Presence in Hepatocytes Perplexed the Possible Mission for a Functional CureSemantic proximity Read ↗

Overview of treatment of hepatitis B: key approaches and clinical challenges.Semantic proximity Read ↗

Hepatitis B: treatment choice and monitoring for response and resistance.Semantic proximity Read ↗

Advances with RNAi-Based Therapy for Hepatitis B Virus InfectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.